1AI ASX · Health Care

Algorae Pharmaceuticals Ltd

Announcements, last 12 months: 86
Price sensitive, last 12 months: 26

Latest announcements

Released	Headline	Actions
19 Oct 2026, 9:00 AM	Algorae executes Licence & Supply Agreement with Umedica Price sensitive
16 Oct 2026, 9:00 AM	Peter Mac partners with Algorae on 3rd AI validation program Price sensitive
7 Oct 2026, 4:46 PM	Notice of Annual General Meeting/Proxy Form
30 Sep 2026, 5:03 PM	Change of Director's Interest Notice - DH
10 Sep 2026, 8:22 AM	Date of AGM and Closing Date for Director Nominations
2 Sep 2026, 5:19 PM	Notification of cessation of securities - 1AI
31 Aug 2026, 4:06 PM	Appendix 4G and Corporate Governance Statement
31 Aug 2026, 4:02 PM	Appendix 4E and 2026 Annual Report Price sensitive	AI summary
31 Jul 2026, 9:14 AM	Quarterly Activities Report/Appendix 4C Cashflow Statement Price sensitive	AI summary
21 Jul 2026, 5:19 PM	Initial Director's Interest Notice - TV

Guidance history

2 Apr 2026

The Company has not provided any high-importance, price-sensitive forward-looking financial metrics or other company-specific metrics.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow 1AI to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.